Free Trial
NASDAQ:OMIC

Singular Genomics Systems (OMIC) Stock Price, News & Analysis

Singular Genomics Systems logo
$20.01 0.00 (0.00%)
As of 02/21/2025

About Singular Genomics Systems Stock (NASDAQ:OMIC)

Key Stats

Today's Range
$20.01
$20.01
50-Day Range
$20.01
$20.01
52-Week Range
$5.34
$23.41
Volume
N/A
Average Volume
52,563 shs
Market Capitalization
$50.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OMIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter.

OMIC Stock News Headlines

Singular Genomics highlights G4X milestones at AGBT
Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
Singular Genomics announces closing of acquisition by Deerfield Managment
Singular Genomics Shareholders Approve Merger Agreement
Singular Genomics Systems Inc
See More Headlines

OMIC Stock Analysis - Frequently Asked Questions

Singular Genomics Systems' stock was trading at $19.43 at the start of the year. Since then, OMIC shares have increased by 3.0% and is now trading at $20.01.

Singular Genomics Systems, Inc. (NASDAQ:OMIC) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($6.72) earnings per share (EPS) for the quarter, topping the consensus estimate of ($8.05) by $1.33. The company earned $0.41 million during the quarter, compared to analysts' expectations of $0.74 million. Singular Genomics Systems had a negative net margin of 3,237.89% and a negative trailing twelve-month return on equity of 57.87%.

Singular Genomics Systems shares reverse split on Wednesday, June 26th 2024.The 1-30 reverse split was announced on Wednesday, June 26th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Singular Genomics Systems (OMIC) raised $178 million in an IPO on Thursday, May 27th 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank served as the underwriters for the IPO.

Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Singular Genomics Systems investors own include NVIDIA (NVDA), Tesla (TSLA), Albemarle (ALB), CrowdStrike (CRWD), Etsy (ETSY), Ford Motor (F) and Fluence Energy (FLNC).

Company Calendar

Last Earnings
11/12/2024
Today
7/13/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:OMIC
CIK
1850906
Fax
N/A
Employees
220
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($35.1096)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$94.82 million
Net Margins
-3,237.89%
Pretax Margin
-3,237.89%
Return on Equity
-57.87%
Return on Assets
-37.90%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
7.37
Quick Ratio
6.67

Sales & Book Value

Annual Sales
$2.91 million
Price / Sales
17.47
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$73.25 per share
Price / Book
0.27

Miscellaneous

Outstanding Shares
2,540,000
Free Float
1,974,000
Market Cap
$50.83 million
Optionable
No Data
Beta
1.83
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:OMIC) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners